riluzole · Italfarmaco Sa · NDA 209080
Tiglutik Kit
Earliest generic entry, as listed
12 Mar 2029
Blocked by patent: US 8765150.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8765150 | product, use U-2401 | 12 Mar 2029 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209080 · 001 · RLD | suspension, oral | 50MG/10ML | 12 Mar 2029 |